RUNX1 and metabolic dysfunction-associated steatotic liver disease: The novelty of this work lies in the fact that we aimed to perform a high-throughput screening to determine the molecular mechanisms that could establish a link between the activity of RUNX1 and NAFLD pathogenesis.